Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Worldwide Shipping!
Find out more »
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
anti-Human Antibodies:
Go to our pre-filtered search.
Human Polyclonal ESRRA Primary Antibody for ICC, IF - ABIN4309527 : Silvennoinen, Rinnankoski-Tuikka, Vuento, Hulmi, Torvinen, Lehti, Kivelä, Kainulainen: High-fat feeding induces angiogenesis in skeletal muscle and activates angiogenic pathways in capillaries. in Angiogenesis 2013 (PubMed) Show all 4 Pubmed References
Bat Polyclonal ESRRA Primary Antibody for ChIP, IHC (p) - ABIN4309525 : Fritah, Steel, Parker, Nikolopoulou, Christian, Carling, Parker: Absence of RIP140 reveals a pathway regulating glut4-dependent glucose uptake in oxidative skeletal muscle through UCP1-mediated activation of AMPK. in PLoS ONE 2012 (PubMed) Show all 3 Pubmed References
ERRalpha is abundantly expressed in H(+)-pump-rich cells, a group of ionocytes responsible for H(+) secretion in the skin of developing embryos, and its expression is stimulated by acidic environments. Knockdown of ERRalpha impairs both basal and low pH-induced H(+) secretion in the yolk-sac (show ADCY10 Antibodies) skin, which is accompanied by decreased expression of H(+)-secreting-related transporters.
Results propose Estrogen Receptor (show ESR1 Antibodies)-Relatedalpha as a new regulator of morphogenetic movement during gastrulation, independently of cell fate determination.
The results identify TGFB1 (show TGFB1 Antibodies) and ESRRA as likely transcriptional regulators of rumen epithelial development and energy metabolism, respectively, and provide targets for modulation of rumen development and function in the growing calf.
ERalpha (show ESR1 Antibodies), is only expressed in the caruncle of the placenta.
ERalpha (show ESR1 Antibodies) mRNA-expressing neurons (ERalpha (show ESR1 Antibodies) neurons) were distributed in some structures of the telencephalon, diencephalon, mesencephalon, and hindbrain.
Findings suggest that PGF (show PGF Antibodies)(2alpha) regulates luteolysis by ESR1 (show ESR1 Antibodies) mRNA down-regulation.
the involvement of ERRalpha in the progression of cisplatin-induced AKI is probably through impaired mitochondrial dynamics
Localizing ESRRA binding sites in cortical chromatin, it has been shown that this nuclear receptor binds both differentially expressed energy-related and neurodevelopmental transcription factor genes during social challenge.
The Genomic Context and Corecruitment of SP1 Affect ERRalpha Coactivation by PGC-1alpha in Muscle Cells
findings highlight a MYC (show MYC Antibodies)/ERRalpha pathway that contributes to physiological and pathological bone loss by integrating the MYC (show MYC Antibodies)/ERRalpha axis to drive metabolic reprogramming during osteoclast differentiation
Study performed a structural and functional assessment of glutamatergic synapses on medium spiny neurons in the nucleus accumbens of Esrra-null mice, and discovered sex-specific alterations in miniature excitatory postsynaptic currents frequency and amplitude, reduced paired-pulse ratio, and reduction in glutamatergic synaptic vesicles consistent with altered functional connectivity
The nuclear receptor, estrogen-related receptor alpha (ERRalpha), was shown to regulate the expression of genes required for lactate utilization.
In bone, the effects of cholesterol, statin, and bisphosphonate on osteoclastogenesis require ERRalpha; and consequently, cholesterol-induced bone loss or bisphosphonate osteoprotection is lost in ERRalpha knockout mice.
We conclude that E2-induced ERRalpha expression in endothelium plays an important role for the E2-induced vasculoprotective effect
Exercise-induced changes in tumour LDH-B (show LDHB Antibodies) and MCT1 (show MCTS1 Antibodies) expression are modulated by oestrogen-related receptor alpha in breast cancer-bearing BALB/c mice
These results indicate that Esrra deficiency in the mouse brain impairs behavioral responses in multiple functional domains.
LC3B (show MAP1LC3B Antibodies) and ESRRA might be a useful prognostic factor in patients with muscle-invasive bladder cancer. The co-expression of LC3B (show MAP1LC3B Antibodies) and ESRRA might be a prognostic and therapeutic target for patients with bladder cancer.
These findings indicate that ERRalpha may serve as a novel molecular target for the treatment of endometrial cancer
Gls (show GLS Antibodies) is a novel ERRalpha target gene.
can trigger the proliferation and migration of colorectal cancer cells via up regulation of IL-8 (show IL8 Antibodies)
curcumin suppressed the ERRalpha gene expression through upregulation of miR (show MLXIP Antibodies)-125a. Data from this study revealed a novel mechanism for curcumin-mediated apoptotic cell death, which involves tumor cell killing via activating miR (show MLXIP Antibodies)-125a/ERRalpha pathway.
blocking the ERRalpha-controlled mitochondrial program largely inhibits the PLA2R1 (show PLA2R1 Antibodies)-induced tumor-suppressive response. Together, our data document ERRalpha and its mitochondrial program as downstream effectors of the PLA2R1 (show PLA2R1 Antibodies)-JAK2 (show JAK2 Antibodies) pathway leading to oncosuppression.
results suggest that the decreased expression of miR (show MLXIP Antibodies)-135a in metastatic tumors leads to elevated ERRalpha expression, resulting in increased cell invasion capacities.
HO-1 (show HMOX1 Antibodies)-derived CO enhances mitochondrial biogenesis in astrocytes by activating L-type Ca(2 (show CA2 Antibodies)+) channel-mediated PGC-1alpha/ERRalpha axis, leading to maintenance of astrocyte function and neuroprotection/recovery against damage of brain function
in ERalpha (show ESR1 Antibodies) negative breast cancer, the low level of ERalpha (show ESR1 Antibodies) reduced miR (show MLXIP Antibodies)-497 expression, which promoted ERRalpha expression that enhanced cell proliferation, migration, and invasion by increasing MIF (show AMH Antibodies) expression and MMP9 (show MMP9 Antibodies) activity.
these data show that ERRalpha expression predicts response to tamoxifen treatment, and ERRalpha could be a biomarker of tamoxifen sensitivity and a prognostic factor in TNBC.
Results show that miR (show MYLIP Antibodies)-125a inhibits porcine preadipocytes differentiation through targeting ERRa.
XCT790 significantly inhibited the expression of ERR alpha and lipid accumulation in porcine mature adipocytes.
The protein encoded by this gene is a nuclear receptor that is closely related to the estrogen receptor. This protein acts as a site-specific transcription regulator and has been also shown to interact with estrogen and the transcripton factor TFIIB by direct protein-protein contact. The binding and regulatory activities of this protein have been demonstrated in the regulation of a variety of genes including lactoferrin, osteopontin, medium-chain acyl coenzyme A dehydrogenase (MCAD) and thyroid hormone receptor genes. A processed pseudogene of ESRRA is located on chromosome 13q12.1.
NR3B1 , estrogen-related receptor 1 , steroid hormone receptor ERR1 , estrogen-related receptor alpha , ERR-alpha , Steroid hormone receptor ERR1 (Estrogen-related receptor, alpha) (ERR-alpha) (Estrogen receptor-like 1) , estrogen receptor related 1 , estrogen receptor-like 1 , nuclear receptor subfamily 3 group B member 1 , estrogen-related receptor, alpha , orphan nuclear receptor , estrogen-related nuclear receptor alpha